Company: TELO
Filing Date: 2025-02-04
Form Type: 10-K
Source: 0001493152-25-004872
Chunk: 190

Company: Telomir Pharmaceuticals, Inc.
Filing Date: 2025-02-04
Form: 10-K
Item: Item 10
Chunk 190
---
3.

In
arriving at these determinations, our board of directors examined all factors relevant to determining whether any compensation committee
member had a relationship to us that is material to that member’s ability to be independent from management in connection with
carrying out such member’s duties as a compensation committee member. 

The
compensation committee’s main purpose is to review and recommend policies relating to compensation and benefits of our officers
and employees. Our compensation committee is responsible for, among other things:

    ●
    reviewing,
    approving, and determining, or making recommendations to our board of directors regarding, the compensation and compensation arrangements
    of our executive officers;

    ●
    administering
    our equity compensation plans;

    ●
    reviewing
    and approving, or making recommendations to our board of directors regarding, incentive compensation and equity compensation plans;
    and

    ●
    establishing
    and reviewing general policies relating to compensation and benefits of our employees.

Our
compensation committee will operate under a written charter that satisfies the applicable rules and regulations of the SEC and the listing
standards of Nasdaq, a copy of which will be available on our website.

59

Nominating
and Corporate Governance Committee

The
nominating and corporate governance committee was established upon the effectiveness of our initial public offering on February 9, 2024
and consists of Dr. Matthew P. Del Giudice and Dr. Craig Eagle, with Matthew P. Del Giudice serving as the chair of the nominating and
corporate governance committee. Each member of the committee meets the requirements for independence under the listing standards of Nasdaq
and SEC rules and regulations.

Our
nominating and corporate governance committee will be responsible for, among other things:

    ●
    identifying,
    evaluating, and selecting, or making recommendations to our board of directors regarding nominees for election to our board of directors
    and its committees;

    ●
    developing
    and overseeing the annual evaluation of our board of directors and of its committees;

    ●
    considering
    and making recommendations to our board of directors regarding the composition of our board of directors and its committees;

    ●
    overseeing
    our corporate governance practices; and

    ●
    making
    recommendations to our board of directors regarding corporate governance guidelines.

Our
nominating and corporate governance committee will operate under a written charter that satisfies the applicable listing standards of
Nasdaq, a copy of which will be available on